Literature DB >> 18710753

Intra-orifice versus hydrodistention implantation technique in dextranomer/hyaluronic acid injection for vesicoureteral reflux.

Amit Gupta1, Warren Snodgrass.   

Abstract

PURPOSE: Original implantation procedures used dextranomer/hyaluronic acid to create a volcano-like mound at the orifice. Subsequently the hydrodistention implantation technique was described to coapt the intramural ureteral wall with less emphasis on achieving a mound at the orifice and it was reported to be associated with improved outcomes. We compared the results of intra-orifice injection to establish a mound vs the hydrodistention implantation technique.
MATERIALS AND METHODS: Univariate and multivariate logistic regression analysis was used to compare results in 96 ureters undergoing intra-orifice injection vs 52 undergoing the hydrodistention implantation technique. We evaluated patient gender and age, reflux grade, injection technique, injected volume and the number of injection sites.
RESULTS: Successful reflux resolution was achieved in 124 ureters (84%) with a single implantation, including 83 (86.5%) with intra-orifice injection and 41 (79%) with HIT (p = 0.23). Mean injected volume was significantly increased for the hydrodistention implantation technique vs intra-orifice injection (0.68 vs 0.51 cc, p = 0.002). Univariate analysis showed that female gender, older age, reflux grade and number of injection sites were associated with success. On multivariate analysis only reflux grade remained significant.
CONCLUSIONS: Despite using an increased volume of dextranomer/hyaluronic acid to coapt the intramural ureter and orifice, the hydrodistention implantation technique did not improve results over those of intra-orifice injection with a lesser implant volume.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710753     DOI: 10.1016/j.juro.2008.04.073

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment.

Authors:  Göran Läckgren; Arne Stenberg
Journal:  Ther Adv Urol       Date:  2009-08

Review 2.  Surgical management of vesicoureteral reflux in children.

Authors:  Jennifer Sung; Steven Skoog
Journal:  Pediatr Nephrol       Date:  2011-06-22       Impact factor: 3.714

3.  Does the modıfıed STING method increase the success rate in the management of moderate or hıgh-grade reflux?

Authors:  Osman Raif Karabacak; Fatih Yalçınkaya; Uğur Altuğ; Nurettin Sertçelik; Fuat Demirel
Journal:  Korean J Urol       Date:  2014-09-05

Review 4.  Endoscopic injection therapy.

Authors:  Sang Woon Kim; Yong Seung Lee; Sang Won Han
Journal:  Investig Clin Urol       Date:  2017-06-02

5.  Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux.

Authors:  Michelle Lightfoot; Aylin N Bilgutay; Noah Tollin; Scott Eisenberg; Jake Weiser; Leah Bryan; Edwin Smith; James Elmore; Hal Scherz; Andrew J Kirsch
Journal:  Front Pediatr       Date:  2019-09-27       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.